IL29369A - Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl)pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines - Google Patents

Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl)pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines

Info

Publication number
IL29369A
IL29369A IL29369A IL2936968A IL29369A IL 29369 A IL29369 A IL 29369A IL 29369 A IL29369 A IL 29369A IL 2936968 A IL2936968 A IL 2936968A IL 29369 A IL29369 A IL 29369A
Authority
IL
Israel
Prior art keywords
methyl
thienyl
formate
trimethylene
process according
Prior art date
Application number
IL29369A
Other languages
English (en)
Original Assignee
Pfizer & Co C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer & Co C filed Critical Pfizer & Co C
Publication of IL29369A publication Critical patent/IL29369A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL29369A 1967-02-14 1968-01-24 Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl)pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines IL29369A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61589767A 1967-02-14 1967-02-14
US64339167A 1967-06-05 1967-06-05
US68190767A 1967-11-09 1967-11-09

Publications (1)

Publication Number Publication Date
IL29369A true IL29369A (en) 1971-05-26

Family

ID=27417162

Family Applications (1)

Application Number Title Priority Date Filing Date
IL29369A IL29369A (en) 1967-02-14 1968-01-24 Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl)pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines

Country Status (11)

Country Link
US (1) US3502661A (no)
BE (1) BE710492A (no)
CH (1) CH498124A (no)
DE (1) DE1695602C3 (no)
ES (1) ES350283A1 (no)
FR (1) FR1588187A (no)
GB (1) GB1195454A (no)
IE (1) IE32035B1 (no)
IL (1) IL29369A (no)
IT (1) IT1047904B (no)
NL (1) NL154509B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006137A (en) * 1975-08-21 1977-02-01 E. R. Squibb & Sons, Inc. 2-Ethenyl imidazolium derivatives
US4087536A (en) * 1976-05-04 1978-05-02 The Dow Chemical Company Method for the use of thienylvinylimidazoles as anthelmintics
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
FR2482859A1 (fr) * 1980-05-22 1981-11-27 Fabre Sa Pierre Fluorhydrates d'heterocycles azotes insatures utilisables en therapeutique dentaire
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
US7858663B1 (en) 2007-10-31 2010-12-28 Pisgah Laboratories, Inc. Physical and chemical properties of thyroid hormone organic acid addition salts
US8039461B1 (en) 2006-11-10 2011-10-18 Pisgah Laboratories, Inc. Physical states of a pharmaceutical drug substance
US20080293695A1 (en) 2007-05-22 2008-11-27 David William Bristol Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
US7718649B1 (en) 2006-11-10 2010-05-18 Pisgah Labs, Inc. Physical states of a pharmaceutical drug substance
US8211905B1 (en) 2007-05-22 2012-07-03 Pisgah Laboratories, Inc. Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
US8329720B1 (en) 2007-05-22 2012-12-11 Pisgah Laboratories, Inc. Opioid salts and formulations exhibiting abuse deterrent and anti-dose dumping properties
US9421266B2 (en) 2007-05-22 2016-08-23 Pisgah Laboratories, Inc. Safety of pseudoephedrine drug products
US10183001B1 (en) 2007-05-22 2019-01-22 Pisgah Laboratories, Inc. Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
US8883863B1 (en) 2008-04-03 2014-11-11 Pisgah Laboratories, Inc. Safety of psuedoephedrine drug products
CA2769385C (en) 2009-07-30 2017-10-17 Merial Limited Insecticidal 4-amino-thieno[2,3-d]-pyrimidine compounds and methods of their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1108207A (en) * 1965-10-07 1968-04-03 Pfizer & Co C Process for preparing 2-Ä2-(substituted) vinylÜcyclic amidines

Also Published As

Publication number Publication date
NL154509B (nl) 1977-09-15
FR1588187A (no) 1970-04-10
GB1195454A (en) 1970-06-17
IE32035B1 (en) 1973-03-21
IT1047904B (it) 1980-10-20
NL6801459A (no) 1968-08-15
US3502661A (en) 1970-03-24
IE32035L (en) 1968-08-14
DE1695602B2 (de) 1974-06-20
ES350283A1 (es) 1969-05-16
DE1695602C3 (de) 1975-03-13
BE710492A (no) 1968-08-08
CH498124A (de) 1970-10-31
DE1695602A1 (de) 1972-04-13

Similar Documents

Publication Publication Date Title
IL29369A (en) Process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl)pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines
CA2155148A1 (en) Pyrrolocarbazoles
KR940008848B1 (ko) 신규의 9-디아자구아닌
DE60116106T2 (de) Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe
EP0217688B1 (fr) Nouveaux dérivés peptidiques à structure lactonique ou cycloamidique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CA1053239A (en) Imidazo (2,1-b) thiazoles
US2425721A (en) Thiophene compounds and methods of obtaining the same
US3458633A (en) Control of helminthiasis with a series of 2-(w-(2-thienyl)alkyl)-,2-(2-(2-thienyl)vinyl)-,and the corresponding isomeric 3-thienyl derivatives of thiazoline and 5,6-dihydro-4h-1,3-thiazine
KR102458638B1 (ko) 메데토미딘의 합성에서 유용한 3-아릴부탄알과 같은 화합물의 제조 방법
US4785012A (en) Oxazole anthelmintic agents of marine origin
SU457221A3 (ru) Способ получени дитиенильных производных
CA1149808A (en) Process for 5-substituted dialuric acids
ES2926579T3 (es) Proceso para la preparación de compuestos intermedios útiles en la preparación de inhibidores del virus de la Hepatitis C (VHC)
US20110071302A1 (en) Process for preparing intermediate compound for synthesizing an antiulcerant
Dains et al. The Alkyl Derivatives of the Mono Substituted Thiazolidones. I
US2745845A (en) 1-formyl-2-dialkoxymethyl-succinic acid esters and their cyclization to heterocyclic compounds
US3828053A (en) Lower-alkyl-beta-oxo-4-piperidine-n-benzoylpropionates
US3072636A (en) Process for the manufacture of ethyleneimine derivatives
Campaigne et al. Halogen—Lithium Interconversion with Iodothiophenes
Cheney et al. Some Tetrahydrothiophene β-Keto Ester Derivatives
IL28815A (en) 1,3-dioxolan-4-yl-alkyl guanidines and process for preparing same
JP2636013B2 (ja) ビス（メチレンジオキシ）ビフェニル化合物
KR960014356B1 (ko) 비스 (메틸렌디옥시)비페닐 화합물
SU250778A1 (ru) Способ получения эфиров хризантемовой пйретровой кислотыили
US3448142A (en) Unsymmetrical djenkolic acid derivatives